FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2023
Back to search
Official data from USPTO
PAUL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/24/2023
Trademark type
Combined
Nice classes
10
Filing date
12/17/2021
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
06/20/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
24
Owner location
SG
Examiner
TULLY, MATTHEW
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ADVANCED OPHTHALMIC INNOVATIONS PTE. LTD.
Representatives
Joseph G. Chu JCIP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Therapeutic instruments for ophthalmologyglaucoma drainage device substantially comprised of drainage tubes for medical or surgical purposes; surgical apparatus and instruments for use for ophthalmology; surgical devices and instruments for use on eyeglaucoma drainage devices and glaucoma filtering devices; implantable ocular device for medical or surgical use as a glaucoma drainage devicesubstantially comprised of drainage tubes for medical or surgical purposes; apparatus for use in surgery in the drainage or control of fluid in eyes; drainage tubes for surgical or medical purposes; surgical instruments for use in eye surgery; ocular implantsglaucoma drainage devices substantially comprised of drainage tubes for medical or surgical purposes; surgical implants made of artificial materials; intra-ocular implantsglaucoma drainage devices substantially comprised of drainage tubes for medical or surgical purposes; implantsocular implants for use as glaucoma drainage devicessubstantially comprised of drainage tubes for medical or surgical purposes
Publications
History of USPTO decisions and trademark events.
29 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/21/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
09/21/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/20/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/17/2023
RFNP
REFUSAL PROCESSED BY IB
01/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/14/2022
RFRR
REFUSAL PROCESSED BY MPU
12/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/04/2022
CNRT
NON-FINAL ACTION WRITTEN
10/03/2022
DOCK
ASSIGNED TO EXAMINER
09/23/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2022
Continuous trademark protection
Get notified about every new filing that threatens PAUL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.